Company / Operating Cash Flow
LivaNova Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$254.3M
FY2025
5-year range
-$91.1M / $254.3M
FY2021-FY2025
Trend
+39.0%
vs FY2024
Sector context
#77 of 164
Health Care
What the data says
At $254M, LivaNova's operating cash flow ranks #77 of 164 in the Health Care sector. Operating Cash Flow has increased for 4 consecutive years, from -$91M in FY2021 to $254M in FY2025.
Based on SEC 10-K filings.
$254M in FY2025.
Improved from $75M to $254M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#77 of 164 in Health CareTop 47% of 164This company $254.3M Sector average $1.0B
▼
-75.6% below sector average
Key checks
Key Insights
- LivaNova's operating cash flow has grown for 4 consecutive years.
- In FY2025, operating cash flow increased 39.0% year-over-year.
- Ranks #77 out of 164 companies in the Health Care sector.
- Lowest operating cash flow in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $254.3M | +39.0% |
| FY2024 | $183.0M | +144.3% |
| FY2023 | $74.9M | +194.3% |
| FY2022 | -$79.4M | +12.9% |
| FY2021 | -$91.1M | -14.8% |
| FY2020 | -$79.4M | +12.9% |
| FY2019 | -$91.1M | -175.6% |
| FY2018 | $120.5M | +31.9% |
| FY2017 | $91.3M | +1.3% |
| FY2016 | $90.2M | +1070.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026